Literature DB >> 12215258

Transcriptional activation of C/EBPbeta gene by c-Jun and ATF2.

Wei-Chin Lin1, Bin-Jon Shen, Yeou-Guang Tsay, Hsueh-Chi Yen, Sheng-Chung Lee, Ching-Jin Chang.   

Abstract

C/EBPbeta is one of the key transcription factors responsible for the induction of a wide array of genes. Like many proto-oncogenes and transcription factors, transcription of C/EBPbeta gene can be induced by multiple extracellular signals. Using nuclear extracts from lipopolysaccharide (LPS)-stimulated mouse liver, five trans-acting factor-binding motifs, URE1 (-376 to -352), URE2 (-253 to -223), URE3 (-220 to -190), URE4 (-123 to -103), and URE5 (-72 to -45) were identified by DNAse I footprinting assays. Competition and supershift analysis of the complexes formed at the URE2 and URE4 indicated that they contain CREB/ATF and AP-1 family factors. Furthermore, recombinant ATF2 and c-Jun proteins from mammalian and bacterial cells can bind to URE2 and URE4 but not URE1. Cotransfection experiments showed that ATF2 and c-Jun activate the C/EBPbeta gene expression cooperatively through URE2 and URE4, and this activation was greatly increased under the treatment of low concentration of anisomycin. During acute phase response, the phosphorylation of c-Jun and ATF2 was found to correlate with C/EBPbeta gene expression. Taken together, our results provide the evidences that both c-Jun and ATF2 are the regulators of C/EBPbeta gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215258     DOI: 10.1089/104454902320308924

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

1.  Loss of c/EBP-beta activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons.

Authors:  Marc W Halterman; Christopher De Jesus; David A Rempe; Nina F Schor; Howard J Federoff
Journal:  Mol Cell Neurosci       Date:  2008-02-13       Impact factor: 4.314

2.  A knowledge-based method to predict the cooperative relationship between transcription factors.

Authors:  Lingyi Lu; Ziliang Qian; XiaoHe Shi; Haipeng Li; Yu-Dong Cai; Yixue Li
Journal:  Mol Divers       Date:  2009-07-10       Impact factor: 2.943

3.  Microarray and proteomics analyses of human intestinal epithelial cells treated with the Aeromonas hydrophila cytotoxic enterotoxin.

Authors:  C L Galindo; A A Fadl; Jian Sha; L Pillai; C Gutierrez; A K Chopra
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Selective abrogation of BiP/GRP78 blunts activation of NF-κB through the ATF6 branch of the UPR: involvement of C/EBPβ and mTOR-dependent dephosphorylation of Akt.

Authors:  Shotaro Nakajima; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Yukinori Saito; Hironori Kato; Tao Huang; Jian Yao; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  Mol Cell Biol       Date:  2011-02-07       Impact factor: 4.272

5.  CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.

Authors:  F Tacke; C Liedtke; S Bocklage; M P Manns; C Trautwein
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

6.  Expression of secreted frizzled-related protein 2 in a primary canine mammary tumor cell line: a candidate tumor marker for mammary tumor cells.

Authors:  Jia-Lin Lee; Ching-Jin Chang; Ling-Ling Chueh; Chung-Tien Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

Review 7.  The role of C/EBPbeta in mammary gland development and breast cancer.

Authors:  Sandra L Grimm; Jeffrey M Rosen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

8.  Cyclic AMP responsive element binding proteins are involved in 'emergency' granulopoiesis through the upregulation of CCAAT/enhancer binding protein β.

Authors:  Hideyo Hirai; Naoka Kamio; Gang Huang; Akiko Matsusue; Shinpei Ogino; Nobuhiko Kimura; Sakiko Satake; Eishi Ashihara; Jiro Imanishi; Daniel G Tenen; Taira Maekawa
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.